The Menlo Park-based molecular diagnostics company is expanding to Austin, with eyes set on completing a 220,000-square-foot facility in EastVillage by 2026.
The Menlo Park-based molecular diagnostics company is expanding to Austin, with eyes set on completing a 220,000-square-foot facility in EastVillage by 2026.
Leave a reply